EMO Biomedicine Corporation was founded in Taipei, Taiwan in 2004. In order to be the world leading company in the field of cellular therapy, EMO has developed necessary platform technologies related to manufacturing and analysis for therapeutic cell- and tissue-based products (HCT/Ps). Since 2004, EMO has been providing comprehensive cell-based bioassays and Contract Research Services to local and global clients, including pharmaceutical and biotech companies. In 2011, EMO started to provide Contract Manufacturing Service of cell-based products to cell therapy companies and hospitals.
Contact
8F., No.29-1, Sec. 2, Zhongzheng E. Rd., Danshui Dist., New Taipei City 251, Taiwan
Tel: +886-2-2809 6390
Shing-Mou Lee, founder and president of EMO Biomedicine, the leading CDMO provider of cell-based products in Taiwan, discusses the major regulatory and maturation trends in the region and shares his…
Shing-Mou Lee, founder and president of EMO Biomedicine, the leading CDMO provider of cell-based products in Taiwan, discusses the major regulatory and maturation trends in the region and shares his…
See our Cookie Privacy Policy Here
